Antimicrobial Peptides: Challenging Journey to the Pharmaceutical, Biomedical, and Cosmeceutical Use

Int J Mol Sci. 2023 May 20;24(10):9031. doi: 10.3390/ijms24109031.

Abstract

Antimicrobial peptides (AMPs), or host defence peptides, are short proteins in various life forms. Here we discuss AMPs, which may become a promising substitute or adjuvant in pharmaceutical, biomedical, and cosmeceutical uses. Their pharmacological potential has been investigated intensively, especially as antibacterial and antifungal drugs and as promising antiviral and anticancer agents. AMPs exhibit many properties, and some of these have attracted the attention of the cosmetic industry. AMPs are being developed as novel antibiotics to combat multidrug-resistant pathogens and as potential treatments for various diseases, including cancer, inflammatory disorders, and viral infections. In biomedicine, AMPs are being developed as wound-healing agents because they promote cell growth and tissue repair. The immunomodulatory effects of AMPs could be helpful in the treatment of autoimmune diseases. In the cosmeceutical industry, AMPs are being investigated as potential ingredients in skincare products due to their antioxidant properties (anti-ageing effects) and antibacterial activity, which allows the killing of bacteria that contribute to acne and other skin conditions. The promising benefits of AMPs make them a thrilling area of research, and studies are underway to overcome obstacles and fully harness their therapeutic potential. This review presents the structure, mechanisms of action, possible applications, production methods, and market for AMPs.

Keywords: antimicrobial peptides; biofilm disruption; drug development; healthcare; immunomodulatory effects; multidrug-resistant pathogens; peptide design and engineering; resistance mechanisms; smart ageing.

Publication types

  • Review

MeSH terms

  • Anti-Bacterial Agents / pharmacology
  • Antimicrobial Cationic Peptides / chemistry
  • Antimicrobial Cationic Peptides / pharmacology
  • Antimicrobial Cationic Peptides / therapeutic use
  • Antimicrobial Peptides*
  • Bacteria
  • Cosmeceuticals* / pharmacology
  • Cosmeceuticals* / therapeutic use

Substances

  • Antimicrobial Peptides
  • Cosmeceuticals
  • Antimicrobial Cationic Peptides
  • Anti-Bacterial Agents

Grants and funding

This research received no external funding.